Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.61 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718008 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL717168 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL169939 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL28984795 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL10871818 | 1.00 | CYP4F2 (0.61) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL28462437 | 0.98 | CYP4F2 (0.59) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL503887 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| Acetic Acid SCHEMBL8601641 | 0.94 | MEN1 (0.58) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL6531912 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT | |
| SCHEMBL369993 | 0.94 | CYP4F2 (0.56) | CYP4F2CYP4A11MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 984 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716378-A | Synthesis method of 1,3, 4-trisubstituted-5-cyanopyrazole derivative | 西华大学 | 2022-07-08 | — | — | CN | claimed |
| CN-113336703-A | Synthesis of 1,3,4, 5-tetrasubstituted 1H-pyrazole derivatives | 西华大学 | 2021-09-03 | — | — | CN | claimed |
| CN-113660932-B | Phenyl derivatives having pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same | 景凯生物科技股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-115515956-B | Benzimidazole derivative, and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| WO-2024117205-A1 | BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT | 北興化学工業株式会社 | 2024-06-06 | — | — | WO | disclosed |
| CN-118126046-A | Substituted macrocyclic compound, and preparation method and application thereof | 深圳信立泰药业股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117999272-A | Peptides | ＡＧＣ株式会社 | 2024-05-07 | — | — | CN | disclosed |
| US-20240147833-A1 | Iridium Complex Compound, Iridium Complex Compound-Containing Composition, Organic Electroluminescent Element, and Method for Manufacturing the Same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-05-02 | — | — | US | disclosed |
| CN-117903094-A | Process for preparing alpha-pyrone-polyketone | 深圳乾延药物研发科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-4349814-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-20240100031-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS CONTAINING PIPERLONGUMINE-BASED COMPOUND AS ACTIVE INGREDIENT | HUSCION CO., LTD. (KR) | 2024-03-28 | — | — | US | disclosed |
| EP-0179428-B1 | INDOLEACETIC ACID DERIVATIVE AND A PHARMACEUTICAL PREPARATION | GREEN CROSS CORPORATION (JP) | 1989-04-05 | — | — | EP | disclosed |
| EP-0289365-A2 | Novel nitrogen-containing compound | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-11-02 | — | — | EP | disclosed |
| EP-0280275-A2 | N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1988-08-31 | — | — | EP | disclosed |
| US-4705554-A | Benzofuranyloxyphenylurea derivative and herbicidal composition containing it as an active ingredient | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-11-10 | — | — | US | disclosed |
| EP-0224816-A1 | Benzofuranyloxyphenylurea derivative and herbicidal composition containing it as an active ingredient | MITSUBISHI KASEI CORPORATION (JP) | 1987-06-10 | — | — | EP | disclosed |
| EP-0183174-A2 | Substituted phenoxy urea, processes for its preparation and herbicide containing it as active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1986-06-04 | — | — | EP | disclosed |
| EP-0179428-A2 | Indoleacetic acid derivative and a pharmaceutical preparation | GREEN CROSS CORPORATION (JP) | 1986-04-30 | — | — | EP | disclosed |
| EP-0157637-A2 | Heterocyclic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-10-09 | — | — | EP | disclosed |
| EP-0125523-A2 | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240100031-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS CONTAINING PIPERLONGUMINE-BASED COMPOUND AS ACTIVE INGREDIENT | SARS1, ACE2, CUL2 | CYP4F2 4126/4885CYP4A11 4165/4885MEN1 3844/4885 |
| US-20240147833-A1 | Iridium Complex Compound, Iridium Complex Compound-Containing Composition, Organic Electroluminescent Element, and Method for Manufacturing the Same | INTS9, IGF1R, INF2 | CYP4F2 1797/4885CYP4A11 2272/4885MEN1 512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.